Investigational Drug Information for ridinilazole
✉ Email this page to a colleague
What is the drug development status for ridinilazole?
ridinilazole is an investigational drug.
There have been 4 clinical trials for ridinilazole.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 19th 2021.
The most common disease conditions in clinical trials are Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are Summit Therapeutics, Department of Health and Human Services, and [disabled in preview].
There is one US patent protecting this investigational drug and fifty-five international patents.
Summary for ridinilazole
| US Patents | 1 |
| International Patents | 55 |
| US Patent Applications | 20 |
| WIPO Patent Applications | 20 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 2 (2021-05-19) |
| Vendors | 32 |
Recent Clinical Trials for ridinilazole
| Title | Sponsor | Phase |
|---|---|---|
| Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects | Department of Health and Human Services | Phase 3 |
| Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects | Summit Therapeutics | Phase 3 |
| Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection | Summit Therapeutics | Phase 3 |
Clinical Trial Summary for ridinilazole
Top disease conditions for ridinilazole
Top clinical trial sponsors for ridinilazole
US Patents for ridinilazole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| ridinilazole | ⤷ Try a Trial | Controlled release dosage form | TRIASTEK, INC. (Nanjing, CN) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for ridinilazole
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| ridinilazole | Australia | AU2017261372 | 2036-05-05 | ⤷ Try a Trial |
| ridinilazole | Canada | CA3023278 | 2036-05-05 | ⤷ Try a Trial |
| ridinilazole | China | CN107847398 | 2036-05-05 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
